Cargando…
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design
The spike protein in SARS-CoV-2 (SARS-2-S) interacts with the human ACE2 receptor to gain entry into a cell to initiate infection. Both Pfizer/BioNTech’s BNT162b2 and Moderna’s mRNA-1273 vaccine candidates are based on stabilized mRNA encoding prefusion SARS-2-S that can be produced after the mRNA i...
Autor principal: | Xia, Xuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829931/ https://www.ncbi.nlm.nih.gov/pubmed/33466921 http://dx.doi.org/10.3390/v13010109 |
Ejemplares similares
-
SARS-CoV-2 variants – Evolution, spike protein, and vaccines
por: Chen, Kai-Wei K., et al.
Publicado: (2022) -
Identification of host receptors for viral entry and beyond: a perspective from the spike of SARS-CoV-2
por: Xia, Xuhua
Publicado: (2023) -
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
por: Almehdi, Ahmed M., et al.
Publicado: (2021) -
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
por: Hussain, Arif, et al.
Publicado: (2020) -
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization
por: Azad, Taha, et al.
Publicado: (2020)